Buy-Side Mandate: Medical Billing / RCM Platform ($500k - $1.5M EBITDA)
January 14, 2026
by a searcher from Arizona State University - W. P. Carey School of Business in Miami, FL, USA
I am an Independent Sponsor executing a roll-up strategy in the Medical Billing / Revenue Cycle Management (RCM) space. We are looking to acquire a platform asset immediately, with a committed capital structure in place to close quickly.
Investment Criteria:
Sector: Medical Billing / RCM (Specialty agnostic, but prefer Cardio, Ortho, or Behavioral Health).
Financials: $500k – $1.5M EBITDA (Platform); $200k+ (Add-ons).
Geography: Nationwide (Remote-first preferred).
Model: Recurring revenue, low customer concentration (<15%).
Deal Structure: We are modeled for a standard leveraged buyout (Senior Debt + Seller Financing). We are SBA-eligible if the asset requires it. We are comfortable with complex deal structures and can move to LOI within 7-14 days of data room access.
For Intermediaries: Buy-side fees are protected. If you have a pocket listing that fits this box, please DM me. We provide feedback on teasers within 24 hours.
from Harvard University in Boston, MA, USA
from Touro University in Bluffton, South Carolina, United States